ATXN2 polyclonal antibody

Catalog # PAB18584

Size

Price

Stock

Quantity

Size:100 ug
Price: USD $ 428.00
Stock:
order now, ship in 5 days
abnova-minus
abnova-plus

* The price is valid only in USA. Please select country.

Contact Info
  • +1-909-264-1399
    +1-909-992-0619
    Toll Free : +1-877-853-6098
  • +1-909-992-3401
  • Specification

    Product Description

    Goat polyclonal antibody raised against synthetic peptide of ATXN2.

    Immunogen

    A synthetic peptide corresponding to amino acids at internal region of human ATXN2.

    Sequence

    C-SEREGHSINTR

    Host

    Goat

    Form

    Liquid

    Purification

    Antigen affinity purification

    Concentration

    0.5 mg/mL

    Recommend Usage

    ELISA (1:2000)
    The optimal working dilution should be determined by the end user.

    Storage Buffer

    In 0.5 mg/mL Tris saline, pH 7.3 (0.02% sodium azide, 0.5% BSA)

    Storage Instruction

    Store at -20°C.
    Aliquot to avoid repeated freezing and thawing.

    Note

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

  • Applications

    Enzyme-linked Immunoabsorbent Assay

  • Gene Info — ATXN2

    Entrez GeneID

    6311

    Protein Accession#

    NP_002964.3

    Gene Name

    ATXN2

    Gene Alias

    ATX2, FLJ46772, SCA2, TNRC13

    Gene Description

    ataxin 2

    Omim ID

    183090 601517

    Gene Ontology

    Hyperlink

    Gene Summary

    The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. Defects in this gene are the cause of spinocerebellar ataxia type 2 (SCA2). SCA2 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. SCA2 is caused by expansion of a CAG repeat in the coding region of this gene. Longer expansions result in earlier onset of the disease. Alternatively spliced transcript variants encoding different isoforms have been identified but their full length sequence has not been determined. [provided by RefSeq

    Other Designations

    olivopontocerebellar ataxia 2, autosomal dominant|spinocerebellar ataxia 2 (olivopontocerebellar ataxia 2, autosomal dominant, ataxin 2)|trinucleotide repeat containing 13

  • Interactome
  • Disease
Contact Info
  • +1-909-264-1399
    +1-909-992-0619
    Toll Free : +1-877-853-6098
  • +1-909-992-3401
4 Products to Compare
Remove All